Join Growin Stock Community!

望隼4771.TW Overview

TW StockBiotech. & Medical
(No presentation for 4771)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

望隼(4771)Overall Performance

望隼(4771)AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

望隼(4771) PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

望隼(4771)Key Information

望隼(4771)Profile

Vizionfocus Inc. engages in the manufacturing of medical equipment in Taiwan, China, Japan, and the United States. It also manufactures mechanical equipment, optical instruments, and precision instruments; trades internationally; and provides other consulting services. In addition, the company engages in the research and development, design, development, production, and wholesale of contact lenses. The company was founded in 2011 and is based in Miaoli, Taiwan.

望隼(4771)FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
12.14
PE Ratio (TTM)
14.62
Forward PE
13.82
PS Ratio (TTM)
3.12
PB Ratio
2.51
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
40.64%
Net Margin
21.36%
Revenue Growth (YoY)
8.25%
Profit Growth (YoY)
9.74%
3-Year Revenue Growth
17.88%
3-Year Profit Growth
17.61%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
12.14
PE Ratio (TTM)
14.62
Forward PE
13.82
PS Ratio (TTM)
3.12
PB Ratio
2.51
Price-to-FCF
-
Gross Margin
40.64%
Net Margin
21.36%
Revenue Growth (YoY)
8.25%
Profit Growth (YoY)
9.74%
3-Year Revenue Growth
17.88%
3-Year Profit Growth
17.61%
default symbol

4771

望隼

177.50D

-1.69%

(-0.02)

  • When is 4771's latest earnings report released?

    The most recent financial report for 望隼 (4771) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating 4771's short-term business performance and financial health. For the latest updates on 4771's earnings releases, visit this page regularly.

  • Where does 4771 fall in the P/E River chart?

    According to historical valuation range analysis, 望隼 (4771)'s current price-to-earnings (P/E) ratio is 11.16, placing it in the Undervalued zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of 4771?

    According to the latest financial report, 望隼 (4771) reported an Operating Profit of 234.48M with an Operating Margin of 27.47% this period, representing a growth of 14.3% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is 4771's revenue growth?

    In the latest financial report, 望隼 (4771) announced revenue of 853.6M, with a Year-Over-Year growth rate of 14.97%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much cash does 4771 have?

    At the end of the period, 望隼 (4771) held Total Cash and Cash Equivalents of 1.18B, accounting for 0.18 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does 4771 go with three margins increasing?

    In the latest report, 望隼 (4771) achieved the “three margins increasing” benchmark, with a gross margin of 40.01%%, operating margin of 27.47%%, and net margin of 24.77%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess 4771's profit trajectory and future growth potential.

  • Is 4771's EPS continuing to grow?

    According to the past four quarterly reports, 望隼 (4771)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 3.3. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of 4771?

    望隼 (4771)'s Free Cash Flow (FCF) for the period is -363.82M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 901.65% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.